Learning Objectives
Upon completion of this program, participants will be better able to:
- Integrate echocardiographic information in clinical decision making.
- Assess ventricular and valvular function using Doppler hemodynamics.
- Describe Doppler assessment of diastolic function/dysfunction.
- Explain new advances in the echocardiographic assessment of left and right ventricular function, including strain and 3D.
- Integrate echocardiographic assessment of cardiomyopathies and systemic diseases in patient management.
- Define clinical uses of TEE and 3D echocardiography.
- Recognize how echocardiography is used to help manage patients with ischemic heart disease.
- Recognize the role of echo contrast and be able to incorporate its use in the echo laboratory.
- Integrate echo information in the management of complex valvular heart disease.
Disclosure:
ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.
While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)
The following faculty members have no relevant financial relationships with ineligible companies:
-
William F. Armstrong, MD
-
Marissa Cristensen, RDCS
-
Andrew de Freitas, MD
-
Nadeen Faza, MD, FASE
-
Renuka Jain, MD, FASE
-
Roberto M. Lang, MD, FASE
-
Steven Lester, MD, FASE
-
Stephen H. Little, MD, FASE
-
Sunil Mankad, MD, FASE
-
Monica Mukherjee, MD, MPH
-
Vera Rigolin, MD, FASE
-
William Zoghbi, MD, FASE
All relevant financial relationships with ineligible companies listed for the following faculty members have been mitigated:
-
Sabe De, MD, FASE - Bayer, Astra Zeneca, Pfizer, Alnylam, Novartis (Speaker/Speaker’s Bureau, Consultant/Advisor); Janssen Canada, Inc., (Speaker/Speaker’s Bureau)
-
Linda D. Gillam, MP, MPH, FASE - Bracco Imaging, Edwards Lifescience, Medtronic, Philips (Consultant or Advisor); Abbott, Edwards Lifesciences, Medtronic (Research Support/Funding)
-
Madeline Jankowski, RDCS, ACS, FASE - Bristol Myers Squibb, Caption Health, Echo IQ (Consultant/Advisor); Bristol Myers Squibb, Caption Health (Educator/Honoraria)
-
Jonathan R. Lindner, MD, FASE - Lantheus Medical Imaging, Philips, NASA, NIH (Research Support/Funding); BioMarin Pharma, Lantheus Medical Imaging, Cytokinetics, NovaPulse, Vibrato Inc. (Consultant/Advisor)
-
Maan Malahfji, MD, FACC - Guerbet (Research Funding)
-
Sharon McCartney, MD, FASE - Humacyte (Consultant/Advisor)
-
Jae K. Oh, MD, FASE - Anuman (Royalties/Patent Beneficiary); Medtronic (Consultant/Advisor); Rednvia (Research Support/ Funding); UpToDate (Editor)
-
Muhamed Saric, MD, PhD, FASE - Abbott, Boston Scientific, Medtronic (Speaker/Speaker’s Bureau); Siemens (Consultant/ Advisor)
-
Gregory Scalia, MBBS, FASE - Abbott, Edwards, Philips, GE (Educator/Honoraria)
-
James Thomas, MD, FASE - Abbott, Caption Health, egnite, GE Healthcare (Educator/Honoraria)
Members of the ASE CME Committee members (not serving as faculty) do not have any financial relationships with ineligible companies. Click here for a list of these members.
None of the ASE staff who were involved in the planning and implementation of this educational activity have relevant financial relationship(s) to disclose with ineligible companies. Click here for a list of ASE staff members.